Page last updated: 2024-10-23

bencyclane and Anemia, Sickle Cell

bencyclane has been researched along with Anemia, Sickle Cell in 1 studies

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research Excerpts

ExcerptRelevanceReference
"Bencyclane appears to be a promising anti-sickling agent that can be used orally in SCD."1.29Bencyclane as an anti-sickling agent. ( Aikimbaev, KS; Başlamişli, F; Güvenç, B; Isbir, T; Koçak, R; Tamer, L, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koçak, R1
Başlamişli, F1
Güvenç, B1
Tamer, L1
Aikimbaev, KS1
Isbir, T1

Other Studies

1 other study available for bencyclane and Anemia, Sickle Cell

ArticleYear
Bencyclane as an anti-sickling agent.
    British journal of haematology, 1996, Volume: 92, Issue:2

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Bencyclane; Ca(2+) Mg(2+)-ATPase; Calci

1996